{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T19:51:52Z","timestamp":1788983512800,"version":"build-2803163510"},"reference-count":14,"publisher":"Wiley","issue":"3","license":[{"start":{"date-parts":[[2021,7,29]],"date-time":"2021-07-29T00:00:00Z","timestamp":1627516800000},"content-version":"vor","delay-in-days":58,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Epileptic Disorders"],"published-print":{"date-parts":[[2021,6]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Autoimmune encephalitis is increasingly recognised as a major cause of new\u2010onset refractory status epilepticus. Early immunotherapy with agents such as methylprednisolone is recommended. Anakinra is an interleukin\u20101 receptor antagonist used for various inflammatory disorders. It has been used successfully in the treatment of febrile infection\u2010related epilepsy syndrome in children and in one adult case. In this case report, we describe a case of super\u2010refractory status epilepticus in a 38\u2010year\u2010old female due to autoimmune encephalitis who was treated successfully with anakinra after 16 weeks of therapeutic coma and failing multiple immunotherapies. Despite a prolonged period of therapeutic coma, this patient made a reasonable recovery with effective communication and ability to walk with assistance upon discharge. We propose that the successful treatment with anakinra in our case could be due to elevated inflammatory cytokines in the pathogenesis of autoimmune encephalitis, although we acknowledge that interleukin levels were unfortunately not available. We conclude that anakinra can be a valuable alternative option in patients with autoimmune encephalitis refractory to conventional immunotherapies.<\/jats:p>","DOI":"10.1684\/epd.2021.1283","type":"journal-article","created":{"date-parts":[[2021,7,13]],"date-time":"2021-07-13T13:07:43Z","timestamp":1626181663000},"page":"500-505","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":23,"title":["Super\u2010refractory status epilepticus in autoimmune encephalitis treated with interleukin\u20101 receptor antagonist, anakinra"],"prefix":"10.1002","volume":"23","author":[{"given":"Chun\u2010ho","family":"Choi","sequence":"first","affiliation":[{"name":"Division of Neurology, Department of Medicine and Therapeutics, Prince of Wales Hospital The Chinese University of Hong Kong China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sze\u2010ho","family":"Ma","sequence":"additional","affiliation":[{"name":"Division of Neurology, Department of Medicine and Therapeutics, Prince of Wales Hospital The Chinese University of Hong Kong China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen KY.","family":"Ma","sequence":"additional","affiliation":[{"name":"Division of Neurology, Department of Medicine and Therapeutics, Prince of Wales Hospital The Chinese University of Hong Kong China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Howan","family":"Leung","sequence":"additional","affiliation":[{"name":"Division of Neurology, Department of Medicine and Therapeutics, Prince of Wales Hospital The Chinese University of Hong Kong China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincent CT.","family":"Mok","sequence":"additional","affiliation":[{"name":"Division of Neurology, Department of Medicine and Therapeutics, Prince of Wales Hospital The Chinese University of Hong Kong China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2021,7,29]]},"reference":[{"key":"e_1_2_7_2_1","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/83.3.357"},{"key":"e_1_2_7_3_1","doi-asserted-by":"publisher","DOI":"10.1177\/1756285617722347"},{"key":"e_1_2_7_4_1","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000001940"},{"key":"e_1_2_7_5_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.seizure.2018.09.018"},{"key":"e_1_2_7_6_1","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2018.01157"},{"key":"e_1_2_7_7_1","doi-asserted-by":"publisher","DOI":"10.1002\/epi4.12317"},{"key":"e_1_2_7_8_1","doi-asserted-by":"publisher","DOI":"10.1002\/ana.24806"},{"issue":"3","key":"e_1_2_7_9_1","first-page":"135","article-title":"Febrile infection\u2010related epilepsy syndrome treated successfully with anakinra in a 21\u2010year\u2010old woman","volume":"118","author":"Westbrook C.","year":"2019","journal-title":"WMJ"},{"key":"e_1_2_7_10_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejpn.2019.08.001"},{"key":"e_1_2_7_11_1","doi-asserted-by":"crossref","first-page":"P4346","DOI":"10.1212\/WNL.90.15_supplement.P4.346","article-title":"Anakinra (IL\u20101 blockade) use in children with suspected FIRES: a single institution experience (P4.346)","volume":"90","author":"Shukla N.","year":"2018","journal-title":"Neurology"},{"key":"e_1_2_7_12_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(15)00401-9"},{"key":"e_1_2_7_13_1","doi-asserted-by":"publisher","DOI":"10.1111\/epi.14016"},{"key":"e_1_2_7_14_1","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1700263"},{"key":"e_1_2_7_15_1","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.02066"}],"container-title":["Epileptic Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1684\/epd.2021.1283","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,18]],"date-time":"2024-03-18T16:14:50Z","timestamp":1710778490000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1684\/epd.2021.1283"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6]]},"references-count":14,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2021,6]]}},"alternative-id":["10.1684\/epd.2021.1283"],"URL":"https:\/\/doi.org\/10.1684\/epd.2021.1283","archive":["Portico"],"relation":{},"ISSN":["1294-9361","1950-6945"],"issn-type":[{"value":"1294-9361","type":"print"},{"value":"1950-6945","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,6]]},"assertion":[{"value":"2020-08-24","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-01-04","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-07-29","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}